Literature DB >> 29405244

Isolated Adrenocorticotropic Hormone Deficiency in Melanoma Patients Treated with Nivolumab.

Seiya Kitano1, Kazuki Tatsuno, Junichi Ishibe, Takatoshi Shimauchi, Toshiharu Fujiyama, Taisuke Ito, Noriyoshi Ogawa, Yoshiki Tokura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29405244     DOI： 10.2340/00015555-2902

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  4 in total

Review 1.  Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.

Authors:  Pedro Iglesias; Juan Cristóbal Sánchez; Juan José Díez
Journal:  Pituitary       Date:  2021-03-24       Impact factor: 4.107

2.  Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab.

Authors:  Wataru Omata; Satoko Nakamura; Chie Urasaki; Hiromichi Morita; Hiroki Funaishi; Kazuki Kobayashi; Hisashi Koide; Arata Tsutsumida; Hiroyuki Matsue
Journal:  Case Rep Dermatol       Date:  2022-03-21

Review 3.  Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.

Authors:  Si-Hong Lin; Ao Zhang; Lu-Zhen Li; Liang-Chen Zhao; Le-Xia Wu; Can-Tu Fang
Journal:  BMC Endocr Disord       Date:  2022-09-24       Impact factor: 3.263

4.  Anti PD-1 immunotherapy related interstitial lung disease presenting as respiratory failure - A review with case series.

Authors:  Padmastuti Akella; Sundaravadivel Loganathan; Vishal Jindal; Jamal Akhtar; Amos Lal
Journal:  Respir Med Case Rep       Date:  2018-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.